TITLE

Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients

AUTHOR(S)
Curran, Adrian; Gutirerrez, Mar; Deig, Elisabet; Mateo, Gracia; Lopez, Rosa Maria; Imaz, Arkaitz; Crespo, Manuel; Ocaña, Inma; Domingo, Pere; Ribera, Esteban
PUB. DATE
October 2010
SOURCE
Journal of Antimicrobial Chemotherapy (JAC);Oct2010, Vol. 65 Issue 10, p2195
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To evaluate the virological efficacy, safety, tolerability and pharmacokinetics of a regimen containing 900/100 mg of ritonavir-boosted darunavir once daily in patients with antiretroviral experience but no darunavir resistance.
ACCESSION #
53882609

 

Related Articles

  • Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam. Lan, Nguyen Thi Ngoc; Thu, Nguyen Thi Nguyet; Barrail-Tran, Aurélie; Duc, Nguyen Hong; Lan, Nguyen Ngoc; Laureillard, Didier; Thi Xuan Lien, Truong; Borand, Laurence; Quillet, Catherine; Connolly, Catherine; Lagarde, Dominique; Pym, Alexander; Lienhardt, Christian; Dung, Nguyen Huy; Taburet, Anne-Marie; Harries, Anthony D // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Rifampicin and protease inhibitors are difficult to use concomitantly in patients with HIV-associated tuberculosis because of drug-drug interactions. Rifabutin has been proposed as an alternative rifamycin, but there is concern that the current recommended dose is suboptimal. The...

  • Analysis of Resistance Testing in South Trinidad. Duke, N.; Aboh, S.; Bosivert, N. // West Indian Medical Journal;2010 Special Issue, Vol. 59 Issue 4, p400 

    The introduction of antiretroviral therapy in Trinidad and Tobago in the 1980s has resulted in a decrease in mortality of HIV-infected persons. Poor adherence to antiretroviral therapy (ART) has resulted in the development of multidrug resistant HIV. Resistance testing done on 40 samples showed...

  • A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study. Edessa, Dumessa; Likisa, Jimma // PLoS ONE;9/8/2015, Vol. 10 Issue 9, p1 

    Background: Tuberculosis (TB) is the most common human immunodeficiency virus (HIV) associated opportunistic infection. It is the leading cause of death in HIV-infected individuals in sub-Saharan Africa. Anti-retroviral therapy (ART) and isoniazid preventive therapy (IPT) are the two useful TB...

  • Reasons Why High Religiosity Can Co-exist with and Precipitate Discontinuation of Anti-retroviral Therapy among Different HIV Clients in Uganda: An Exploratory Study. Tumwine, Christopher; Neema, Stella; Wagner, Glenn // Religions;Sep2012, Vol. 3 Issue 3, p817 

    In-depth interviews were conducted with 39 very religious people living with HIV (16 had ever and 23 had never discontinued antiretroviral therapy--ART) to assess the role of religion in these treatment decisions and in coping with HIV. Participants who had ever discontinued ART gave reasons...

  • Use of first line antiretroviral therapy from a free ART programme clinic in Pune, India - A preliminary report. Ghate, Manisha; Tripathy, Srikanth; Gangakhedkar, Raman; Thakar, Madhuri; Bhattacharya, Jayanta; Choudhury, Ipsita; Risbud, Arun; Bembalkar, Shilpa; Kadam, Dileep; Rewari, Bharat B.; Paranjape, Ramesh // Indian Journal of Medical Research;May2013, Vol. 137 Issue 5, p942 

    Background & objectives: The treatment outcomes under national antiretroviral therapy (ART) programme are being evaluated in some ART centres in the country. We carried out this study to analyze the impact of first line antiretroviral therapy in HIV infected patients attending a free ART roll...

  • Immunologic response among HIV-infected patients enrolled in a graduated cost-recovery programme of antiretroviral therapy delivery in Chennai, India. Solomon, Sunil Suhas; Ganesh, Aylur K.; Mehta, Shruti H.; Yepthomi, Tokugha; Balaji, Kavitha; Anand, Santhanam; Gallant, Joel E.; Solomon, Suniti // Indian Journal of Medical Research;Jun2013, Vol. 137 Issue 6, p1145 

    Background & objectives: Sustainability of free antiretroviral therapy (ART) roll out programmes in resource-limited settings is challenging given the need for lifelong therapy and lack of effective vaccine. This study was undertaken to compare treatment outcomes among HIV-infected patients...

  • Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. Cardoso, Sandra Wagner; Luz, Paula Mendes; Velasque, Luciane; Torres, Thiago S.; Tavares, Isabel C.; Ribeiro, Sayonara Rocha; Moreira, Ronaldo Ismério; Veloso, Valdilea Gonçalves; Moore, Richard D.; Grinsztejn, Beatriz // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p780 

    Background World-wide, the notable expansion of HIV/AIDS treatment programs in resource-limited settings has lead to an increasing number of patients in need of second-line cART. To adequately address and prepare for this scenario, critical assessments of the outcomes of second-line cART are...

  • Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. Ingle, Suzanne M.; May, Margaret T.; Gill, M. John; Mugavero, Michael J.; Lewden, Charlotte; Abgrall, Sophie; Fätkenheuer, Gerd; Reiss, Peter; Saag, Michael S.; Manzardo, Christian; Grabar, Sophie; Bruyand, Mathias; Moore, David; Mocroft, Amanda; Sterling, Timothy R.; D'Arminio Monforte, Antonella; Hernando, Victoria; Teira, Ramon; Guest, Jodie; Cavassini, Matthias // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 2, p287 

    Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific death varied by ART duration and were strongly related to age, sex, and transmission risk group. Deaths from non-AIDS malignancies were much more frequent than those from cardiovascular...

  • Department of Health is dragging feet on HIV rule.  // British Dental Journal;11/13/2010, Vol. 209 Issue 9, p429 

    The article offers information on the withdrawal of rules regarding the treatment of HIV patients by the positive members of the dental team which was challenged by Dental Protection Ltd. against the Department of Health (DH) since anti-retroviral medication is already available to control the...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics